Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Lymphoma development and survival in refractory coeliac disease type II: Histological response as prognostic factor.

Nijeboer P, van Wanrooij R, van Gils T, Wierdsma NJ, Tack GJ, Witte BI, Bontkes HJ, Visser O, Mulder C, Bouma G.

United European Gastroenterol J. 2017 Mar;5(2):208-217. doi: 10.1177/2050640616646529. Epub 2016 Jun 23.

2.

Serum intestinal-fatty acid binding protein as a biomarker for refractory celiac disease.

Gross S, Adriaanse MP, Nijeboer P, Tack GJ, van Hoogstraten IM, Bouma G, Mulder CJ, von Blomberg BM, Vreugdenhil AC, Bontkes HJ.

J Gastrointestin Liver Dis. 2015 Jun;24(2):258-9. No abstract available.

3.

An unusual cause of duodenal obstruction in adults.

Tack GJ, van Kelckhoven BJ, Kuyvenhoven JP.

Arab J Gastroenterol. 2015 Jun;16(2):63-5. doi: 10.1016/j.ajg.2015.03.002. Epub 2015 Apr 21.

PMID:
25910574
4.

Beneficial pharmacological interaction between thiopurine and mesalazine—never change a winning team.

Tack GJ, Waayenberg P, de Boer NK.

J Crohns Colitis. 2014 Dec;8(12):1743-4. doi: 10.1016/j.crohns.2014.08.003. Epub 2014 Aug 28. No abstract available.

PMID:
25175784
5.

Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.

Tack GJ, van de Water JM, Bruins MJ, Kooy-Winkelaar EM, van Bergen J, Bonnet P, Vreugdenhil AC, Korponay-Szabo I, Edens L, von Blomberg BM, Schreurs MW, Mulder CJ, Koning F.

World J Gastroenterol. 2013 Sep 21;19(35):5837-47. doi: 10.3748/wjg.v19.i35.5837.

6.

[A women with an altered defaecation pattern].

Tack GJ, van Kelckhoven BJ, Kuyvenhoven JP.

Ned Tijdschr Geneeskd. 2013;157(41):A6501. Dutch.

PMID:
24103136
7.

Update on the diagnosis and management of refractory coeliac disease.

Nijeboer P, van Wanrooij RL, Tack GJ, Mulder CJ, Bouma G.

Gastroenterol Res Pract. 2013;2013:518483. doi: 10.1155/2013/518483. Epub 2013 May 9.

8.

Antibody titers against food antigens decrease upon a gluten-free diet, but are not useful for the follow-up of (refractory) celiac disease.

Gross S, van Wanrooij RL, Tack GJ, Gelderman KA, Bakker SF, van Hoogstraten IM, Neefjes-Borst EA, Schreurs MW, Bouma G, Mulder CJ, von Blomberg BM, Bontkes HJ.

Eur J Gastroenterol Hepatol. 2013 Apr;25(4):516-8. doi: 10.1097/MEG.0b013e32835dca77. No abstract available.

PMID:
23337171
9.

Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies.

Adriaanse MP, Tack GJ, Passos VL, Damoiseaux JG, Schreurs MW, van Wijck K, Riedl RG, Masclee AA, Buurman WA, Mulder CJ, Vreugdenhil AC.

Aliment Pharmacol Ther. 2013 Feb;37(4):482-90. doi: 10.1111/apt.12194. Epub 2013 Jan 7.

10.

Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing--a cohort study.

Tack GJ, van Wanrooij RL, Von Blomberg BM, Amini H, Coupe VM, Bonnet P, Mulder CJ, Schreurs MW.

BMC Gastroenterol. 2012 Nov 12;12:159. doi: 10.1186/1471-230X-12-159.

11.

Tioguanine in the treatment of refractory coeliac disease--a single centre experience.

Tack GJ, van Asseldonk DP, van Wanrooij RL, van Bodegraven AA, Mulder CJ.

Aliment Pharmacol Ther. 2012 Aug;36(3):274-81. doi: 10.1111/j.1365-2036.2012.05154.x. Epub 2012 May 30.

12.

Origin and immunophenotype of aberrant IEL in RCDII patients.

Tack GJ, van Wanrooij RL, Langerak AW, Tjon JM, von Blomberg BM, Heideman DA, van Bergen J, Koning F, Bouma G, Mulder CJ, Schreurs MW.

Mol Immunol. 2012 Apr;50(4):262-70. doi: 10.1016/j.molimm.2012.01.014. Epub 2012 Feb 23.

PMID:
22364936
13.

DNAM-1 mediates epithelial cell-specific cytotoxicity of aberrant intraepithelial lymphocyte lines from refractory celiac disease type II patients.

Tjon JM, Kooy-Winkelaar YM, Tack GJ, Mommaas AM, Schreurs MW, Schilham MW, Mulder CJ, van Bergen J, Koning F.

J Immunol. 2011 Jun 1;186(11):6304-12. doi: 10.4049/jimmunol.1003382. Epub 2011 Apr 27.

14.

Evaluation of Cladribine treatment in refractory celiac disease type II.

Tack GJ, Verbeek WH, Al-Toma A, Kuik DJ, Schreurs MW, Visser O, Mulder CJ.

World J Gastroenterol. 2011 Jan 28;17(4):506-13. doi: 10.3748/wjg.v17.i4.506.

15.

Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy.

Tack GJ, Wondergem MJ, Al-Toma A, Verbeek WH, Schmittel A, Machado MV, Perri F, Ossenkoppele GJ, Huijgens PC, Schreurs MW, Mulder CJ, Visser OJ.

Bone Marrow Transplant. 2011 Jun;46(6):840-6. doi: 10.1038/bmt.2010.199. Epub 2010 Sep 6.

PMID:
20818442
16.

Accurate classification of RCD requires flow cytometry.

van Wanrooij RL, Schreurs MW, Bouma G, von Blomberg BM, Tack GJ, Verbeek WH, Mulder CJ.

Gut. 2010 Dec;59(12):1732. doi: 10.1136/gut.2010.223438. Epub 2010 Aug 30. No abstract available.

PMID:
20805314
17.

Phenotypic and genomic analysis of an exceptional case of enteropathy associated T-cell lymphoma.

Tack GJ, Verbeek WH, van de Water JM, von Blomberg BM, Bhola SL, Ylstra B, Mulder CJ, Schreurs MW.

Leuk Res. 2010 Aug;34(8):e183-9. doi: 10.1016/j.leukres.2010.02.018. Epub 2010 Mar 11. No abstract available.

PMID:
20226524
18.

The spectrum of celiac disease: epidemiology, clinical aspects and treatment.

Tack GJ, Verbeek WH, Schreurs MW, Mulder CJ.

Nat Rev Gastroenterol Hepatol. 2010 Apr;7(4):204-13. doi: 10.1038/nrgastro.2010.23. Epub 2010 Mar 9. Review.

PMID:
20212505
19.

Multiple common variants for celiac disease influencing immune gene expression.

Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, Curtotti A, Zhernakova A, Heap GA, Adány R, Aromaa A, Bardella MT, van den Berg LH, Bockett NA, de la Concha EG, Dema B, Fehrmann RS, Fernández-Arquero M, Fiatal S, Grandone E, Green PM, Groen HJ, Gwilliam R, Houwen RH, Hunt SE, Kaukinen K, Kelleher D, Korponay-Szabo I, Kurppa K, MacMathuna P, Mäki M, Mazzilli MC, McCann OT, Mearin ML, Mein CA, Mirza MM, Mistry V, Mora B, Morley KI, Mulder CJ, Murray JA, Núñez C, Oosterom E, Ophoff RA, Polanco I, Peltonen L, Platteel M, Rybak A, Salomaa V, Schweizer JJ, Sperandeo MP, Tack GJ, Turner G, Veldink JH, Verbeek WH, Weersma RK, Wolters VM, Urcelay E, Cukrowska B, Greco L, Neuhausen SL, McManus R, Barisani D, Deloukas P, Barrett JC, Saavalainen P, Wijmenga C, van Heel DA.

Nat Genet. 2010 Apr;42(4):295-302. doi: 10.1038/ng.543. Epub 2010 Feb 28. Erratum in: Nat Genet.2010 May;42(5):465.

20.

Disappointing outcome of allogeneic hematopoietic SCT in two EATL patients.

Regelink JC, Tack GJ, Huijgens PC, Mulder CJ, Janssen JJ, Visser O.

Bone Marrow Transplant. 2010 May;45(5):959-60. doi: 10.1038/bmt.2009.250. Epub 2009 Oct 12. No abstract available.

PMID:
19820724

Supplemental Content

Support Center